Cosunter was once again approved as a “Hi-tech Enterprise”

HEPA2015 published the 96-week clinical data for EnGanDing Capsules, showing it is equivalent to the imported Entecavir Capsules in terms of clinical effect

“A kind of entecavir solid dispersion and its pharmaceutical composition, preparation method and pharmaceutical application” was granted the “Seventeenth Chinese Excellent Patent Award”

The wholly-owned subsidiary Fujian Cosunter Pharmaceutical Sales Co., Ltd. was established

Cosunter was once again approved as a “Hi-tech Enterprise”

Fujian CapitalBio MedLab Co., Ltd. was jointly established by Cosunter and Beijing CapitalBio MedLab, starting the new exploration in genetic testing and precision medical fields

Cosunter was successfully listed on the Shenzhen Stock Exchange (stock code: 300436), becoming the first private pharmaceutical company in Fujian Province to be listed on the A-share market

“A kind of entecavir solid dispersion and its pharmaceutical composition, preparation method and pharmaceutical application” was awarded the “Second Prize of the 2014 Patent Award of Fujian Province”

“A first-line treatment for hepatitis B virus - new drug development of Entecavir APIs and preparations” was awarded the “Third Prize of the 2014 Science and Technology Progress Award of Fujian Province”

All existing production lines passed the new version of GMP certification

Cosunter was included in the “Top Ten Taxpayers” in Ningde in 2013

Cosunter was rated as the “Most Valued Enterprises in China” for two consecutive years

Cosunter was rated as a “Key Hi-Tech Enterprises in the National Torch Plan”

Shareholding reform was completed and Cosunter embarked on the journey of going public

“HeGanDing” Lamivudine and “EnGanDing” Entecavir came into the market, making Cosunter the only R&D and production enterprise in China having three anti-HBV clinical drugs

First class national new drug “AGanDing” Adefovir Dipivoxil was awarded the “First Prize of the 2010 Technological Innovation Award of Fujian Province” and the “Special Award of the 2010 Patent Award of Fujian Province”

First class national new drug “AGanDing” Adefovir Dipivoxil was awarded the “First Prize of the 2010 Technological Innovation Award of Fujian Province” and the “Special Award of the 2010 Patent Award of Fujian Province”

AGanDing was awarded “the First Prize of the Excellent New Product Award of Fujian Province”

Cosunter was listed in the first batch of “Patent Pilot Enterprises” in Ningde

First class national new drug – “AGanDing” Adefovir Dipivoxil tablets went on the market

Cosunter was rated as one of the 2015 “Top 100 High-potential enterprises in China” by Forbes China

Cosunter was rated as one of the “Top 500 Most Competitive SMEs” in China

Construction of the production base of Cosunter began

EFFORT GROUP purchased the Mindong No. 2 Pharmaceutical Co., Ltd. and established Cosunter Pharmaceutical Co., Ltd.